Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.315 +0.015 (+1.15%)

Streaming Delayed Price Updated: 12:41 PM EDT, May 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial ↗

November 09, 2021

The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Inc's (NASDAQ: INO) COVID-19 vaccine in the U.S. Inovio said it...

Via Benzinga

Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases

November 09, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the...

Via FinancialNewsMedia

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 09, 2021

Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...

Via Benzinga

AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio ↗

November 01, 2021

MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage ↗

October 18, 2021

Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral...

Via Talk Markets

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Is This The Turning Point for Inovio? ↗

October 06, 2021

The biotech's streak of bad luck may be about to end, but risks remain.

Via The Motley Fool

Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine

October 20, 2021

Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing...

Via FinancialNewsMedia

New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab

October 06, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in...

Via FinancialNewsMedia

Is Vaccine Latecomer Inovio Making a Comeback? ↗

September 29, 2021

Its new plan for phase 3 trials is advancing.

Via The Motley Fool

As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024

September 23, 2021

Via FinancialNewsMedia

Looking Into Inovio Pharmaceuticals's Return On Capital Employed ↗

September 16, 2021

Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting...

Via Benzinga

Etsy And NetApp Lead The S&P 500 ↗

August 26, 2021

U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and...

Via Benzinga

Topics Economy Stocks

Why Inovio Stock Is Jumping Today ↗

August 26, 2021

The vaccine maker received some good news from Brazil.

Via The Motley Fool

Inovio Pharmaceuticals Stock Nears End Of Technical Pattern ↗

August 26, 2021

Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading...

Via Benzinga

Inovio To Start Global Late-Stage COVID-19 Vaccine Trial ↗

August 26, 2021

The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-...

Via Benzinga

Why Inovio's Stock Is Trading Higher Today ↗

August 26, 2021

Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the...

Via Benzinga

August 25, 2021

Not every stock on the popular trading app is worth owning.

Via The Motley Fool

Why Dynavax, Novavax, and Inovio Stocks Sank This Week ↗

August 20, 2021

Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.

Via The Motley Fool

Unusual Options Activity Insight: Inovio Pharmaceuticals ↗

August 18, 2021

On Wednesday, shares of Inovio Pharmaceuticals (NASDAQ:INO) saw unusual options activity. After the option alert, the stock price moved down to $8.29. Sentiment: BULLISH Option...

Via Benzinga

3 Scary COVID Stocks to Avoid ↗

August 17, 2021

Our Fool roundtable picks three COVID stocks they think are dangerous at these prices.

Via The Motley Fool

Apple And Salesforce Lead The DIA In A Mixed Day Of Trading ↗

August 12, 2021

U.S. indices had a mixed day of trading Thursday as traders and investors weigh COVID-19 variant updates, recent earnings and the recently passed $1 trillion...

Via Benzinga

77 Biggest Movers From Yesterday ↗

August 13, 2021

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...

Via Benzinga

Watch Out: Inovio Pharmaceuticals Is Heating Up ↗

August 12, 2021

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta...

Via Benzinga

85 Biggest Movers From Yesterday ↗

August 11, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...

Via Benzinga

Why Inovio Pharmaceuticals Is Plunging Today ↗

August 10, 2021

Solid business developments did not please investors.

Via The Motley Fool

Why Inovio's Stock Is Trading Lower Today ↗

August 10, 2021

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results....

Via Benzinga

54 Stocks Moving In Tuesday's Mid-Day Session ↗

August 10, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...

Via Benzinga

Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

INO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.